Incidence and groups at risk for unexpected uterine leiomyosarcoma: a Dutch nationwide cohort study
Author:
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology,General Medicine
Link
http://link.springer.com/article/10.1007/s00404-018-4949-4/fulltext.html
Reference20 articles.
1. Stentz NC, Cooney LG, Sammel M et al (2017) Changes in myomectomy practice after the U.S. Food and Drug Administration Safety Communication on power morcellation. Obstet Gynecol 129(6):1007–1013
2. Singh SS, Bougie O, Arendas K et al (2015) Morcellation in anada: perspectives on current practices and future implications. J Minim Invasive Gynecol 22(7):1142–1144
3. Lum DA, Sokol ER, Berek JS et al (2016) Impact of the 2014 Food and Drug Administration warnings against power morcellation. J Minim Invasive Gynecol 23(4):548–556
4. Mandato VD, Torricelli F, Pirillo D et al (2016) Impact of the Food and Drug Administration Safety Communication on the use of power morcellator in daily clinical practice: an Italian survey. J Minim Invasive Gynecol 23(2):206–214
5. Saadat S, Arden D (2017) How has the FDA morcellation warning affected rates of minimally invasive hysterectomy?[30G]. Obstet Gynecol 129:79S
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prognostic analysis of different pathological types of uterine sarcoma;2024-05-30
2. Incidentally Detected Uterine Sarcomas in Patients Operated with Myoma Uteri in a Tertiary Center: Retrospective Cohort Study;Journal of Clinical Obstetrics & Gynecology;2024
3. High negative prediction for the Basel sarcoma score: Sonographic assessment of features suspicious of uterine sarcoma;Gynecologic Oncology;2023-07
4. Accuracy of Frozen Section and Clinical/Radiological Diagnosis with Final Histopathology of Pelvic Masses in a Teaching Institute with a Non-oncology Setup, in Northeast India;The Journal of Obstetrics and Gynecology of India;2023-06-29
5. Clinical manifestations and prognosis of unexpected uterine sarcoma of uterine fibroids in Tianjin China;BMC Women's Health;2022-12-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3